These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31485643)

  • 1. CFHR1 is a potentially downregulated gene in lung adenocarcinoma.
    Wu G; Yan Y; Wang X; Ren X; Chen X; Zeng S; Wei J; Qian L; Yang X; Ou C; Lin W; Gong Z; Zhou J; Xu Z
    Mol Med Rep; 2019 Oct; 20(4):3642-3648. PubMed ID: 31485643
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wu G; Zhao Z; Yan Y; Zhou Y; Wei J; Chen X; Lin W; Ou C; Li J; Wang X; Xiong K; Zhou J; Xu Z
    Ann Transl Med; 2020 Mar; 8(6):341. PubMed ID: 32355785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of highly expressed PAICS in lung adenocarcinoma.
    Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
    Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
    Zhao W; Wang J; Luo Q; Peng W; Li B; Wang L; Zhang C; Duan C
    BMC Med Genomics; 2020 Dec; 13(1):185. PubMed ID: 33308216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
    Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T
    Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
    Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
    Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis.
    Ge Z; Liu H; Ji T; Liu Q; Zhang L; Zhu P; Li L; Zhu L
    Bioengineered; 2022 Jan; 13(1):1276-1287. PubMed ID: 34738865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
    Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of
    Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.
    Yao S; Wu D; Chen J; Wang P; Lv X; Huang J
    FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 13. Function of low ADARB1 expression in lung adenocarcinoma.
    Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
    PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
    Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A
    Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.
    Rogers LM; Mott SL; Smith BJ; Link BK; Sahin D; Weiner GJ
    Clin Cancer Res; 2017 Feb; 23(4):954-961. PubMed ID: 27528699
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma.
    Yan Y; Xu Z; Qian L; Zeng S; Zhou Y; Chen X; Wei J; Gong Z
    Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L630-L643. PubMed ID: 30604627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma.
    Li Z; Qi F; Li F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.